Improved outcomes for HPV-positive head and neck cancer with cetuximab and IMRT
Studies have shown higher survival rates for people with head and neck cancers that test positive for HPV when they are treated with systemic chemotherapy and radiation therapy. Now a new study suggests outcomes are also better when radiation therapy is combined with cetuximab, a targeted therapy. The data will be presented at the annual meeting of the American Society for Radiation Oncology, October 31st through November 4th in San Diego. The study, conducted at Georgetown Lombardi Comprehensive Cancer Center, analyzed tumors from sequentially treated patients between 2007 and 2009 with head and neck squamous cell carcinoma that were treated with cetuximab and intensity-modulated radiation therapy (IMRT). Of these patients, six had stage III disease and 14 had stage IVa disease. The median age was 63 (age ranged from 31 to 78). The patients received IMRT for seven to eight weeks (media dose was 72.0 Gy). Cetuximab was given for a media of seven cycles. Primary tumor sites included oral cavity (1), oropharynx (12), hypopharynx (1), larynx (5), and with one site unknown.
After a median follow up of 19 months, four patients had died and 12 patients had disease progression.
"We found a statistically significant higher progression free survival rates when comparing the outcomes of patients with HPV-positive tumors to those with HPV-negative tumors," explains Keith Unger, MD, lead author of the study.
One-year progression free survival rates were 100 percent for those with HPV-positive tumors and 31 percent for those who were HPV negative. Two year progression free survival rates were 60 percent for those with HPV compared to 23 percent for those with HPV negative tumors (p=0.05).
While not statistically significant, researchers observed a trend in improved overall survival. One-year overall survival rates were 100 percent for those with HPV-positive tumors versus 83 percent in HPV-negative tumors. Two-year survival rates were 100 percent for HPV-positive tumors compared to 71 percent for HPV negative tumors (p=0.12).
"We found no correlation between overall survival or progression free survival and stage, nodal status, primary site, or the duration of radiotherapy," Unger concludes.
Source: Georgetown University Medical Center
Articles on the same topic
- Radiation before surgery keeps colorectal cancer from returning14 years ago
- Aspirin use associated with lower risk of cancer death for men with prostate cancer14 years ago
- Prostate cancer screening improves quality of life by catching disease before it spreads14 years ago
- Adding radiation to hormone therapy for prostate cancer treatment will increase survival chances14 years ago
- Newer, more intense chemotherapy with less radiation not more effective against Hodgkin's lymphoma14 years ago
- Highly targeted radiation technique minimizes side effects of prostate cancer treatment14 years ago
- Chemotherapy plus radiation prevents bladder cancer recurrences14 years ago
- Radiation therapy improves painful condition associated with multiple sclerosis14 years ago
- Practice-changing studies on how oncologists treat cancer to be presented at ASTRO Annual Meeting14 years ago
Other sources
- Newer type of radiation for prostate cancer favored in reviewsfrom Physorg14 years ago
- Targeted radiation therapy minimizes GI side effects for prostate cancer patients, Penn study showsfrom Science Blog14 years ago
- Adding radiation to hormone therapy for prostate cancer treatment will increase survival chances, study suggestsfrom Science Daily14 years ago
- Aspirin use associated with lower risk of cancer death for men with prostate cancerfrom Science Daily14 years ago
- Prostate cancer screening improves quality of life by catching disease before it spreads, study findsfrom Science Daily14 years ago
- Radiation before surgery keeps colorectal cancer from returning, study findsfrom Science Daily14 years ago
- Highly targeted radiation technique minimizes side effects of prostate cancer treatment, study findsfrom Science Daily14 years ago
- Newer, more intense chemotherapy with less radiation not more effective against Hodgkin's lymphoma, study findsfrom Science Daily14 years ago
- Chemotherapy plus radiation prevents bladder cancer recurrences, study findsfrom Science Daily14 years ago
- Highly targeted radiation technique minimizes side effects of prostate cancer treatmentfrom Physorg14 years ago
- Newer, more intense chemotherapy with less radiation not more effective against Hodgkin's lymphomafrom Physorg14 years ago
- Improved outcomes for HPV-positive head and neck cancer with cetuximab and IMRTfrom Physorg14 years ago
- Improved outcomes for HPV-positive head and neck cancer with cetuximab and IMRT, study suggestsfrom Science Daily14 years ago
- Radiation therapy improves painful condition associated with multiple sclerosis, study findsfrom Science Daily14 years ago
- Prostate cancer screening improves quality of life by catching disease before it spreadsfrom Physorg14 years ago
- Chemotherapy plus radiation prevents bladder cancer recurrencesfrom Physorg14 years ago
- Radiation before surgery keeps colorectal cancer from returningfrom Physorg14 years ago
- Adding radiation to hormone therapy for prostate cancer treatment will increase survival chancesfrom Physorg14 years ago
- Aspirin use associated with lower risk of cancer death for men with prostate cancerfrom Physorg14 years ago
- Radiation therapy improves painful condition associated with multiple sclerosisfrom Physorg14 years ago
- Vitamin E in front line of prostate cancer fightfrom Science Daily14 years ago
- Practice-changing studies on how oncologists treat cancer to be presented at ASTRO Annual Meetingfrom Science Blog14 years ago
- Add warnings to prostate cancer hormones: FDAfrom CBC: Health14 years ago